After attracting public attention in the offset of the COVID-19 pandemic, germicidal UV irradiation (GUVI) now faces a set of pressing challenges. Addressing them will give the technology a serious chance in the indoor air disinfection industry. The ball is now in the court of product suppliers who are ready to tackle present and future…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
